Seqens Seqens

X

Digital content for AriBio

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
AriBio
korearepublicofnew Flag
Country
Country
South Korea
Address
Address
#520, F5, Gyeonggi Bussiness Growth Support Center, 42, Changeop-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.businesswire.com/news/home/20240324642699/en

BUSINESSWIRE
24 Mar 2024

https://www.businesswire.com/news/home/20240223840537/en

BUSINESSWIRE
25 Feb 2024

https://www.businesswire.com/news/home/20231114680663/en

BUSINESSWIRE
14 Nov 2023

https://www.businesswire.com/news/home/20230331005009/en

BUSINESSWIRE
31 Mar 2023

https://www.businesswire.com/news/home/20230308005122/en

BUSINESSWIRE
08 Mar 2023

https://www.businesswire.com/news/home/20230105005102/en

BUSINESSWIRE
05 Jan 2023

https://www.businesswire.com/news/home/20220503006378/en

BUSINESSWIRE
04 May 2022

https://www.businesswire.com/news/home/20211220005951/en

BUSINESSWIRE
20 Dec 2021

http://www.koreabiomed.com/news/articleView.html?idxno=12209

Shim Hyun-tai KOREABIOMED
23 Sep 2021

https://www.biospace.com/article/releases/aribio-co-ltd-announces-last-patient-last-visit-in-phase-2-clinical-trial-of-ar1001-in-mild-to-moderate-alzheimer-s-patients/

BIOSPACE
21 Jan 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY